TL;DR
This study investigated whether PET imaging with the tracer [<sup>18</sup>F]-Flortaucipir (FTP) could detect tau pathology (a hallmark of CTE-NC) in former professional American-style football (ASF) players. Contrary to some prior suggestions, the researchers found no significant differences in FTP uptake between former ASF players and controls, nor did they find associations between FTP uptake and objective cognitive function, questioning FTP PET's current clinical utility for diagnosing CTE-NC in this population.
What Problem Does This Paper Address?
Chronic Traumatic Encephalopathy Neuropathological Change (CTE-NC) is a neurodegenerative disease linked to repetitive head impacts (RHI), common in American-style football (ASF) players. Currently, a definitive diagnosis of CTE-NC can only be made post-mortem through brain examination, specifically by identifying hyperphosphorylated tau (p-Tau). This lack of an antemortem diagnostic tool hinders the development of effective treatments. Positron Emission Tomography (PET) with tracers like [<sup>18</sup>F]-Flortaucipir (FTP) has shown promise in detecting p-Tau in living individuals, leading to interest in its application for former ASF players. However, previous studies have yielded mixed results, creating a need to further evaluate FTP PET's utility in this specific population and its correlation with both football exposure and cognitive function.
Methods
The study employed a case-control design, comparing former professional ASF players with age-matched male controls. Both groups underwent structural MRI for anatomical reference. PET scans were performed using two tracers: [<sup>18</sup>F]-Flortaucipir (FTP) to assess p-Tau and [<sup>11</sup>C]-PiB to assess amyloid-beta (Aβ) burden. Former ASF players also completed a battery of neuropsychological tests measuring memory, executive function, and depression symptom severity. Football exposure was quantified through various metrics, including age at first exposure, career duration, and self-reported concussion signs and symptoms. Statistical analyses included voxelwise linear regression to compare FTP uptake between groups and to assess associations between FTP uptake and various football exposure metrics, as well as neurocognitive outcomes. Sensitivity analyses were conducted on subsets of the player cohort to explore specific subgroups.
Datasets
The study utilized data from two primary sources:
- Former ASF Players: 27 former professional American-style football players recruited through the Football Players Health Study (FPHS) at Harvard University.
- Control Participants: 11 age-matched male controls recruited from the Framingham Heart Study cohort.
No new benchmarks were introduced; the study aimed to validate and expand upon existing findings using comparable methodologies.
Key Insights and Ideas
- No Blanket Increase in Tau: The most striking finding is the absence of elevated p-Tau (as measured by FTP uptake) in former ASF players compared to controls, even in brain regions previously implicated in CTE-NC. This challenges the assumption that all former ASF players will exhibit detectable tau pathology with current PET tracers.
- Cognitive Function Disconnect: Crucially, there was no association found between FTP uptake and objective measures of neurocognitive functioning. This suggests that if tau pathology is present in these players, it's not directly correlating with their current cognitive performance as measured by the tests used.
- Entorhinal Cortex Nuance: A marginally significant association was found between professional career duration and FTP uptake specifically in the entorhinal cortex. This region is known to be involved in age-related tau aggregation and Alzheimer's disease, hinting at a potential, albeit weak, link that warrants further investigation.
- Race and Off-Target Binding: The study noted potential race-associated differences in off-target binding of FTP to neuromelanin in the hippocampus, particularly in Black former ASF players. This raises concerns about FTP's specificity in diverse populations and its potential confounding effects.
Key Results
- No Group Differences: Voxelwise linear regression analyses showed no significant differences in [<sup>18</sup>F]-FTP uptake between former ASF players (n=27) and controls (n=11) across the brain.
- No Amyloid Burden: No participant, in either group, had significant amyloid-beta burden.
- No Association with Cognition: Among ASF participants, no associations were found between objective neurocognitive functioning measures and [<sup>18</sup>F]-FTP uptake.
- Marginal Entorhinal Cortex Finding: A marginally significant association (p=0.05) was observed between professional NFL career duration and [<sup>18</sup>F]-FTP uptake in the entorhinal cortex, after adjusting for age, position, and race.
- Concussion Burden: Former ASF players reported an average of 34.4 ± 37.2 concussion signs and symptoms.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Control Sample: The control group was small (n=11) and comprised solely of white participants, potentially limiting the generalizability of comparisons. However, they argue that a larger, more diverse control group might not have revealed differences if the effect size is small.
- Age Dependency: While sensitivity analyses for older players didn't reveal differences, the possibility that FTP uptake is age-dependent and might only be detectable in extreme phenotypes remains.
- Multiple Comparisons: The study did not adjust for multiple comparisons to maintain statistical power for their a priori hypotheses, which means the marginally significant finding in the entorhinal cortex could be a false positive.
Future work should focus on:
- Newer Tau PET Tracers: Investigating the diagnostic accuracy of next-generation p-Tau PET tracers that might offer better specificity.
- Clinical Correlates: Further exploring the clinical correlates of entorhinal cortex tau uptake.
- Alternative Pathologies: Investigating other potential drivers of neurocognitive impairment in former ASF players, such as hypertension, mood disorders, chronic inflammation, and sleep disturbances, which might be overlooked.
- Diverse Populations: Addressing the potential confounding effects of neuromelanin binding in diverse populations, particularly in regions like the hippocampus.
Summary updated